729 related articles for article (PubMed ID: 30022119)
1. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
Dev H; Chiang TW; Lescale C; de Krijger I; Martin AG; Pilger D; Coates J; Sczaniecka-Clift M; Wei W; Ostermaier M; Herzog M; Lam J; Shea A; Demir M; Wu Q; Yang F; Fu B; Lai Z; Balmus G; Belotserkovskaya R; Serra V; O'Connor MJ; Bruna A; Beli P; Pellegrini L; Caldas C; Deriano L; Jacobs JJL; Galanty Y; Jackson SP
Nat Cell Biol; 2018 Aug; 20(8):954-965. PubMed ID: 30022119
[TBL] [Abstract][Full Text] [Related]
2. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
[TBL] [Abstract][Full Text] [Related]
3. The dystonia gene THAP1 controls DNA double-strand break repair choice.
Shinoda K; Zong D; Callen E; Wu W; Dumitrache LC; Belinky F; Chari R; Wong N; Ishikawa M; Stanlie A; Multhaupt-Buell T; Sharma N; Ozelius L; Ehrlich M; McKinnon PJ; Nussenzweig A
Mol Cell; 2021 Jun; 81(12):2611-2624.e10. PubMed ID: 33857404
[TBL] [Abstract][Full Text] [Related]
4. The shieldin complex mediates 53BP1-dependent DNA repair.
Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
[TBL] [Abstract][Full Text] [Related]
5. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
[TBL] [Abstract][Full Text] [Related]
6. An OB-fold complex controls the repair pathways for DNA double-strand breaks.
Gao S; Feng S; Ning S; Liu J; Zhao H; Xu Y; Shang J; Li K; Li Q; Guo R; Xu D
Nat Commun; 2018 Sep; 9(1):3925. PubMed ID: 30254264
[TBL] [Abstract][Full Text] [Related]
7. 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.
Ghezraoui H; Oliveira C; Becker JR; Bilham K; Moralli D; Anzilotti C; Fischer R; Deobagkar-Lele M; Sanchiz-Calvo M; Fueyo-Marcos E; Bonham S; Kessler BM; Rottenberg S; Cornall RJ; Green CM; Chapman JR
Nature; 2018 Aug; 560(7716):122-127. PubMed ID: 30046110
[TBL] [Abstract][Full Text] [Related]
8. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
[TBL] [Abstract][Full Text] [Related]
9. 53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis.
Mirman Z; Sasi NK; King A; Chapman JR; de Lange T
Nat Cell Biol; 2022 Jan; 24(1):51-61. PubMed ID: 35027730
[TBL] [Abstract][Full Text] [Related]
10. FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.
Tomida J; Takata KI; Bhetawal S; Person MD; Chao HP; Tang DG; Wood RD
EMBO J; 2018 Jun; 37(12):. PubMed ID: 29789392
[TBL] [Abstract][Full Text] [Related]
11. SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.
Findlay S; Heath J; Luo VM; Malina A; Morin T; Coulombe Y; Djerir B; Li Z; Samiei A; Simo-Cheyou E; Karam M; Bagci H; Rahat D; Grapton D; Lavoie EG; Dove C; Khaled H; Kuasne H; Mann KK; Klein KO; Greenwood CM; Tabach Y; Park M; Côté JF; Masson JY; Maréchal A; Orthwein A
EMBO J; 2018 Sep; 37(18):. PubMed ID: 30154076
[TBL] [Abstract][Full Text] [Related]
12. Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells.
Tang M; Chen Z; Wang C; Feng X; Lee N; Huang M; Zhang H; Li S; Xiong Y; Chen J
J Biol Chem; 2022 Jun; 298(6):101979. PubMed ID: 35472331
[TBL] [Abstract][Full Text] [Related]
13. The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity.
Becker JR; Cuella-Martin R; Barazas M; Liu R; Oliveira C; Oliver AW; Bilham K; Holt AB; Blackford AN; Heierhorst J; Jonkers J; Rottenberg S; Chapman JR
Nat Commun; 2018 Dec; 9(1):5406. PubMed ID: 30559443
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors.
Barazas M; Gasparini A; Huang Y; Küçükosmanoğlu A; Annunziato S; Bouwman P; Sol W; Kersbergen A; Proost N; de Korte-Grimmerink R; van de Ven M; Jonkers J; Borst GR; Rottenberg S
Cancer Res; 2019 Feb; 79(3):452-460. PubMed ID: 30530501
[TBL] [Abstract][Full Text] [Related]
15. CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining.
Iyer DR; Harada N; Clairmont C; Jiang L; Martignetti D; Nguyen H; He YJ; Chowdhury D; D'Andrea AD
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2214935119. PubMed ID: 36442094
[TBL] [Abstract][Full Text] [Related]
16. Regulation of DNA double-strand break repair pathway choice: a new focus on 53BP1.
Zhang F; Gong Z
J Zhejiang Univ Sci B; 2021 Jan; 22(1):38-46. PubMed ID: 33448186
[TBL] [Abstract][Full Text] [Related]
17. TRIP13 regulates DNA repair pathway choice through REV7 conformational change.
Clairmont CS; Sarangi P; Ponnienselvan K; Galli LD; Csete I; Moreau L; Adelmant G; Chowdhury D; Marto JA; D'Andrea AD
Nat Cell Biol; 2020 Jan; 22(1):87-96. PubMed ID: 31915374
[TBL] [Abstract][Full Text] [Related]
18. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
Tarsounas M; Sung P
Nat Rev Mol Cell Biol; 2020 May; 21(5):284-299. PubMed ID: 32094664
[TBL] [Abstract][Full Text] [Related]
19. Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
Zatreanu D; Robinson HMR; Alkhatib O; Boursier M; Finch H; Geo L; Grande D; Grinkevich V; Heald RA; Langdon S; Majithiya J; McWhirter C; Martin NMB; Moore S; Neves J; Rajendra E; Ranzani M; Schaedler T; Stockley M; Wiggins K; Brough R; Sridhar S; Gulati A; Shao N; Badder LM; Novo D; Knight EG; Marlow R; Haider S; Callen E; Hewitt G; Schimmel J; Prevo R; Alli C; Ferdinand A; Bell C; Blencowe P; Bot C; Calder M; Charles M; Curry J; Ekwuru T; Ewings K; Krajewski W; MacDonald E; McCarron H; Pang L; Pedder C; Rigoreau L; Swarbrick M; Wheatley E; Willis S; Wong AC; Nussenzweig A; Tijsterman M; Tutt A; Boulton SJ; Higgins GS; Pettitt SJ; Smith GCM; Lord CJ
Nat Commun; 2021 Jun; 12(1):3636. PubMed ID: 34140467
[TBL] [Abstract][Full Text] [Related]
20. CHAMP1-POGZ counteracts the inhibitory effect of 53BP1 on homologous recombination and affects PARP inhibitor resistance.
Fujita H; Ikeda M; Ui A; Ouchi Y; Mikami Y; Kanno SI; Yasui A; Tanaka K
Oncogene; 2022 May; 41(19):2706-2718. PubMed ID: 35393543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
